Calithera Biosciences Inc
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Calithera Biosciences Inc - Asset Resilience Ratio
Calithera Biosciences Inc (CALA) has an Asset Resilience Ratio of 0.00% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2021)
This chart shows how Calithera Biosciences Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Calithera Biosciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Calithera Biosciences Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Calithera Biosciences Inc Industry Peers by Asset Resilience Ratio
Compare Calithera Biosciences Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
464680
KQ:464680 |
Shell Companies | 97.32% |
|
Azure Holding Group Corp
PINK:AZRH |
Shell Companies | 0.00% |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880 |
Shell Companies | 93.60% |
|
Cuspis Capital II Ltd
V:CCII-P |
Shell Companies | 97.65% |
|
0041B0
KQ:0041B0 |
Shell Companies | 77.82% |
|
Aloys Inc.
KQ:297570 |
Shell Companies | 1.22% |
|
Nh Special Purpose Acquisition 14 Co. Ltd
KQ:319400 |
Shell Companies | 1.35% |
Annual Asset Resilience Ratio for Calithera Biosciences Inc (2014–2021)
The table below shows the annual Asset Resilience Ratio data for Calithera Biosciences Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.00% | $0.00 | $64.76 Million | -- |
| 2020-12-31 | 6.37% | $8.01 Million | $125.59 Million | -51.06pp |
| 2019-12-31 | 57.43% | $96.92 Million | $168.77 Million | -2.19pp |
| 2018-12-31 | 59.62% | $85.09 Million | $142.72 Million | -0.30pp |
| 2017-12-31 | 59.92% | $115.32 Million | $192.46 Million | -15.23pp |
| 2016-12-31 | 75.15% | $41.18 Million | $54.80 Million | -9.10pp |
| 2015-12-31 | 84.25% | $63.82 Million | $75.75 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $104.77 Million | -- |